- Trials with a EudraCT protocol (34)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (16)
34 result(s) found for: Lips.
Displaying page 1 of 2.
EudraCT Number: 2012-000058-73 | Sponsor Protocol Number: LIPS | Start Date*: 2012-09-14 | |||||||||||
Sponsor Name:University of Liverpool [...] | |||||||||||||
Full Title: A multi-centre (UK) double-blind randomised parallel group placebo controlled trial to evaluate the efficacy, safety, and tolerability of Intravenous Immunoglobulin (IVIg) 0.5g/kg plus standard tre... | |||||||||||||
Medical condition: Complex Regional Pain Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001670-28 | Sponsor Protocol Number: BER-1272-0058-I | Start Date*: 2013-03-18 | |||||||||||
Sponsor Name:Medizinische Fakultät der Technischen Universität München | |||||||||||||
Full Title: Angiotensin Converting Enzyme Inhibitor (ACE) Induced Angioedema BERINERT Randomized, double-blind, two arms, multicenter, Phase III study of Berinert for treatment of ACE induced Angioedema | |||||||||||||
Medical condition: Angiotensin – Converting – Enzyme – Inhibitors (ACEi) are used in the treatment of several types of cardiovascular and renal diseases. A known side effect of ACEi are angioedema of the head and ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002783-27 | Sponsor Protocol Number: KAWA2019-1962 | Start Date*: 2020-03-04 | |||||||||||
Sponsor Name:Amsterdam University Medical Center | |||||||||||||
Full Title: A 12-month, open-label, parallel-cohort study to evaluate the efficacy, safety and tolerability of Canakinumab in Kawasaki disease | |||||||||||||
Medical condition: Active Kawasaki disease | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015410-22 | Sponsor Protocol Number: AMACE | Start Date*: 2010-04-30 |
Sponsor Name:Medizinische Fakultaet der Technischen Universitaet Muenchen | ||
Full Title: A multicenter, randomized, double-blind study with 2 groups as prove of concept for the treatment of ACE induced angioedema with subcutaneous Icatibant | ||
Medical condition: The study objective is to assess the efficacy and safety of the Bradykinin-2 (BK-2) receptor antagonist Icatibant compared to a historic group of 47 patients with ACE inhibitor induced angioedema w... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-001474-27 | Sponsor Protocol Number: Baceca-030-BCC | Start Date*: 2005-07-07 |
Sponsor Name:TopoTarget A/S | ||
Full Title: A randomised, double-blinded parallel group study to compare efficacy and tolerability of topically applied Baceca and Tazarotene against placebo and Tazarotene in patients with basal cell carcinoma | ||
Medical condition: skin cancer of the type of Basal Cell Carcinoma (BCC) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-002632-15 | Sponsor Protocol Number: BAK-08 | Start Date*: 2008-10-10 |
Sponsor Name:Birken GmbH | ||
Full Title: Randomized, multicenter, double blind study to compare the efficacy and tolerability of Oleogel-S-10 for 3 months versus placebo only in patients with mild to moderate ac-tinic keratoses located at... | ||
Medical condition: Die Studie ist eine randomisierte, multizentrische, doppelt verblindete Studie zum Vergleich der Wirksamkeit und Verträglichkeit einer Behandlung mit Oleogel-S-10 über 3 Monate vs. Placebo bei Pati... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005788-24 | Sponsor Protocol Number: BA2005/21/02 | Start Date*: 2007-02-15 |
Sponsor Name:Bioalliance Pharma | ||
Full Title: A Randomised, Double-Blind, Single dose, One-Day Early Administration, Multicentre Study comparing the Efficacy and Safety of Acyclovir Lauriad 50 mg muco-adhesive buccal tablet to matching Placebo... | ||
Medical condition: Herpes labialis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) DE (Completed) FR (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-005332-29 | Sponsor Protocol Number: D-Vitaal1.0 | Start Date*: 2013-01-23 |
Sponsor Name:VU University Medical Centre | ||
Full Title: Prevention of depression and poor physical function in older persons with vitamin D supplementation | ||
Medical condition: depressive symptoms, poor physical functioning. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-004433-17 | Sponsor Protocol Number: 124210 | Start Date*: 2020-02-18 | |||||||||||
Sponsor Name:MRC CTU at UCL | |||||||||||||
Full Title: Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary arte... | |||||||||||||
Medical condition: Kawasaki Disease | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Ongoing) EE (Ongoing) SE (Ongoing) FI (Ongoing) ES (Ongoing) DE (Ongoing) NL (Ongoing) IT (Ongoing) AT (Ongoing) CZ (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012063-33 | Sponsor Protocol Number: H 569 000-0908 | Start Date*: 2009-08-10 | |||||||||||
Sponsor Name:Almirall Hermal GmbH | |||||||||||||
Full Title: Double-blind, randomized, multi-centre phase II study to evaluate the efficacy and safety of topically applied LAS41007 once daily and LAS41007 twice daily versus Solaraze® 3% gel twice daily in th... | |||||||||||||
Medical condition: Patients aged 18 and older suffering from actinic keratoses. Patients to be considered have at least four and up to ten actinic keratoses of grade I to grade II in two treatment blocks of 25 cm2 ea... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001890-15 | Sponsor Protocol Number: SD-809-C-18 | Start Date*: 2014-11-12 |
Sponsor Name:Auspex Pharmaceuticals, Inc. | ||
Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF SD-809 (DEUTETRABENAZINE) FOR THE TREATMENT OF MODERATE TO SEVERE TARDIVE DYSKINESIA | ||
Medical condition: Tardive Dyskinesia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) PL (Completed) SK (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002326-39 | Sponsor Protocol Number: 1-10-72-57-15 | Start Date*: 2015-08-19 | |||||||||||
Sponsor Name:Gynecology Department,Herning Hospital [...] | |||||||||||||
Full Title: The influence of fat intake, estrogen, age, and gender on postprandial lipds and glucose | |||||||||||||
Medical condition: Healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004015-21 | Sponsor Protocol Number: CA-P-3978-01 | Start Date*: 2006-08-31 | |||||||||||
Sponsor Name:Johnson & Johnson Consumer and Personal Products Worldwide | |||||||||||||
Full Title: Randomized Clinical Study Comparing Compeed Cold Sore Patch to Zovirax Cream 5% in the Treatment of Herpes Labialis | |||||||||||||
Medical condition: Herpes Labialis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022244-20 | Sponsor Protocol Number: H 569 000 – 1004 | Start Date*: 2010-10-15 | |||||||||||
Sponsor Name:Almirall S.A. | |||||||||||||
Full Title: Double-blind, randomized, vehicle- and comparator-controlled, multicenter trial to evaluate the efficacy and safety of LAS41007 in the treatment of actinic keratosis | |||||||||||||
Medical condition: Patients aged 18 and older suffering from actinic keratosis. Patients to be considered have at least 6 but no more than 16 clinically confirmed AK target lesions of mild to moderate intensity in up... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001438-25 | Sponsor Protocol Number: VWM1 | Start Date*: 2020-04-21 |
Sponsor Name:VU University Medical Center | ||
Full Title: A Study to Explore the Safety, Tolerability, Pharmacokinetic Profile, and Potential Efficacy of Guanabenz in Patients With Early Childhood Onset Vanishing White Matter (VWM) | ||
Medical condition: Vanishing white matter | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003613-28 | Sponsor Protocol Number: CLFX453X2201 | Start Date*: 2014-12-17 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized, vehicle controlled, active comparator, parallel group study to evaluate safety, tolerability and preliminary efficacy of topical LFX453 formulations in patients with actinic keratosis | |||||||||||||
Medical condition: Actinic keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) IS (Completed) DE (Completed) DK (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003135-19 | Sponsor Protocol Number: SD-809-C-23 | Start Date*: 2015-02-06 |
Sponsor Name:Auspex Pharmaceuticals, Inc. | ||
Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FIXED-DOSE STUDY OF SD-809 (DEUTETRABENAZINE) FOR THE TREATMENT OF MODERATE TO SEVERE TARDIVE DYSKINESIA | ||
Medical condition: Tardive Dyskinesia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SK (Completed) PL (Completed) CZ (Completed) HU (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-022980-37 | Sponsor Protocol Number: H 1005 6002 - 1007 | Start Date*: 2010-12-09 | |||||||||||
Sponsor Name:Almirall Hermal GmbH | |||||||||||||
Full Title: A prospective comparator controlled randomized exploratory study on the efficacy of LAS 41005 compared to cryotherapy in subjects with hyperkeratotic actinic keratosis | |||||||||||||
Medical condition: Actinic keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007072-42 | Sponsor Protocol Number: 20599 | Start Date*: 2008-07-08 | |||||||||||
Sponsor Name:University Medical Center Utrecht | |||||||||||||
Full Title: Double-blind placebo-controlled randomized study to determine the effectiveness of magnesium oxide to reduce the prostate motion. | |||||||||||||
Medical condition: Prostate cancer patients who are being treated with external beam radiotherapy using fiducial marker-based position verification. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003194-22 | Sponsor Protocol Number: APHP200009 | Start Date*: Information not available in EudraCT |
Sponsor Name:Assistance Publique – Hôpitaux de Paris (AP-HP) | ||
Full Title: A RANDOMIZED PHASE III MULTICENTER TRIAL COMPARING THE EFFICACY AND SAFETY OF ANAKINRA VERSUS INTRAVENOUS IMMUNOGLOBULIN (IVIG) RETREATMENT, IN PATIENTS WITH KAWASAKI DISEASE WHO FAILED TO RESPOND ... | ||
Medical condition: Anakinra treatment is expected to reduce the early and long-term mortality of patients with Kawasaki Disease (KD), by a rapid and sustained effect on vascular inflammation. | ||
Disease: | ||
Population Age: Infants and toddlers, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.